新型心源性细胞因子GDF3预测心肌梗死后不良纤维化重构
研究通过生物信息学分析小鼠心脏基质PW1+细胞分泌组,发现心梗后GDF3分泌增加并促进成纤维细胞增殖;在80例首发ST段抬高型心梗患者中,血浆GDF3水平与6个月不良重构风险独立相关。
要点
- 心梗后心脏基质PW1+细胞分泌GDF3增多,通过激活素受体样激酶促进成纤维细胞增殖。
- 人血浆GDF3在心梗后数日显著升高,可作为促纤维化旁分泌信号的循环标志物。
核心结论
- 心脏基质细胞通过分泌GDF3等心源性细胞因子促进梗死后纤维化重构,循环GDF3是心梗后不良纤维化重构的候选标志物。
研究设计与样本
- 对正常及心梗后小鼠心脏基质PW1+细胞进行生物信息学分泌组分析,并用功能实验筛选促纤维化分泌蛋白。
- 在小鼠和人类心脏及血浆中分析候选因子表达,并在80例首发ST段抬高型心梗患者中结合系列心脏磁共振评估循环GDF3与不良重构的关系。
主要发现
- 心梗后心脏基质PW1+细胞旁分泌行为改变,其条件培养基显著促进成纤维细胞增殖。
- 共鉴定出12个心梗后PW1+细胞过表达的分泌蛋白候选,其中GDF3在缺血心脏中显著上调。
- 富集GDF3的条件培养基通过刺激激活素受体样激酶高水平诱导成纤维细胞增殖。
- GDF3可在小鼠和人血浆中检测到,心梗后数日显著升高。
临床怎么用
- 心梗后第4天血浆GDF3或可辅助识别6个月不良纤维化重构高风险患者,但需进一步验证后用于临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Myocardial infarction (MI) induces a repair response that ultimately generates a stable fibrotic scar. Although the scar prevents cardiac rupture, an excessive profibrotic response impairs optimal recovery by promoting the development of noncontractile fibrotic areas. The mechanisms that lead to cardiac fibrosis are diverse and incompletely characterized. We explored whether the expansion of cardiac fibroblasts after MI can be regulated through a paracrine action of cardiac stromal cells. METHODS: We performed a bioinformatic secretome analysis of cardiac stromal PW1+ cells isolated from normal and post-MI mouse hearts to identify novel secreted proteins. Functional assays were used to screen secreted proteins that promote fibroblast proliferation. The expressions of candidates were subsequently analyzed in mouse and human hearts and plasmas. The relationship between levels of circulating protein candidates and adverse post-MI cardiac remodeling was examined in a cohort of 80 patients with a first ST-segment-elevation MI and serial cardiac magnetic resonance imaging evaluations. RESULTS: Cardiac stromal PW1+ cells undergo a change in paracrine behavior after MI, and the conditioned media from these cells induced a significant increase in the proliferation of fibroblasts. We identified a total of 12 candidates as secreted proteins overexpressed by cardiac PW1+ cells after MI. Among these factors, GDF3 (growth differentiation factor 3), a member of the TGF-β (transforming growth factor-β) family, was markedly upregulated in the ischemic hearts. Conditioned media specifically enriched with GDF3 induced fibroblast proliferation at a high level by stimulation of activin-receptor-like kinases. In line with the secretory nature of this protein, we next found that GDF3 can be detected in mice and human plasma samples, with a significant increase in the days after MI. In humans, higher GDF3 circulating levels (measured in the plasma at day 4 after MI) were significantly associated with an increased risk of adverse remodeling 6 months after MI (adjusted odds ratio, 1.76 [1.03-3.00]; P=0.037), including lower left ventricular ejection fraction and a higher proportion of akinetic segments. CONCLUSIONS: Our findings define a mechanism for the profibrotic action of cardiac stromal cells through secreted cardiokines, such as GDF3, a candidate marker of adverse fibrotic remodeling after MI. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT01113268.
引用
- Masurkar, Bouvet, Logeart, et al. Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction. Circulation. 2022. PMID: 36484260. doi:10.1161/CIRCULATIONAHA.121.056272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。